Dendritic-cell- and peptide-based vaccination strategies for glioma

Neurosurgical Review

Volumn 32, Issue 3, 2009, Pages 265-273

  Yamanaka, Ryuya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dendritic cells; Glioma; Immunotherapy; Peptide vaccination

Indexed keywords

CANCER ANTIBODY; DENDRITIC CELL VACCINE; PEPTIDE VACCINE;

AUTOIMMUNE DISEASE; CLINICAL TRIAL; GLIOMA; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNOLOGY; TUMOR RECURRENCE; VACCINATION;

ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CANCER VACCINES; CLINICAL TRIALS AS TOPIC; DENDRITIC CELLS; GLIOMA; HUMANS; IMMUNOTHERAPY; VACCINES, SUBUNIT;

EID: 67349223911     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-009-0189-1     Document Type: Review

References (63)

1. SM Barratt-Boyes MI Zimmer LA Harshyne EM Meyer SC Watkins S Capuano 3rd M Murphey-Corb LD Falo Jr AD Donnenberg 2000 Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines J Immunol 164 2487 2495 (Pubitemid 30115478)
2. M Bax JJ García-Vallejo J Jang-Lee SJ North TJ Gilmartin G Hernández PR Crocker H Leffler SR Head SM Haslam A Dell Y van Kooyk 2007 Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins J Immunol 179 12 8216 8224
3. JG Cairncross K Ueki MC Zlatescu DK Lisle DM Finkelstein RR Hammond JS Silver PC Stark DR Macdonald Y Ino DA Ramsay DN Louis 1998 Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 90 19 1473 1479 (Pubitemid 28482012)
4. YT Chen MJ Scanlan U Sahin O Türeci AO Gure S Tsang B Williamson E Stockert M Pfreundschuh LJ Old 1997 A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening Proc Natl Acad Sci USA 94 1914 1918 (Pubitemid 27113936)
5. IJ de Vries WJ Lesterhuis NM Scharenborg LP Engelen DJ Ruiter MJ Gerritsen S Croockewit CM Britten R Torensma GJ Adema CG Figdor CJ Punt 2003 Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients Clin Cancer Res 9 14 5091 5100 (Pubitemid 37413557)
6. MV Dhodapkar RM Steinman 2002 Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans Blood 100 1 174 177 (Pubitemid 35177444)
7. AB Dietz PA Bulur GJ Knutson R Matasić S Vuk-Pavlović 2000 Maturation of human monocyte-derived dendritic cells studied by microarray hybridization Biochem Biophys Res Commun 275 3 731 738 (Pubitemid 30708229)
8. S Grabbe E Kämpgen G Schuler 2000 Dendritic cells: multi-lineal and multi functional Immunol Today 21 431 433 (Pubitemid 30693861)
9. OM Grauer S Nierkens E Bennink LW Toonen L Boon P Wesseling RP Sutmuller GJ Adema 2007 CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo Int J Cancer 121 1 95 105 (Pubitemid 46753856)
10. M Hatano J Eguchi T Tatsumi N Kuwashima JE Dusak MS Kinch IF Pollack RL Hamilton WJ Storkus H Okada 2005 EphA2 as a glioma-associated antigen: a novel target for glioma vaccines Neoplasia 7 717 722
11. + glioma patients Oncol Rep 17 629 636
12. ME Hegi AC Diserens T Gorlia MF Hamou N de Tribolet M Weller JM Kros JA Hainfellner W Mason L Mariani JE Bromberg P Hau RO Mirimanoff JG Cairncross RC Janzer R Stupp 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 10 997 1003 (Pubitemid 40349502)
13. T Imaizumi T Kuramoto K Matsunaga S Shichijo S Yutani M Shigemori K Oizumi K Itoh 1999 Expression of the tumor-rejection antigen SART1 in brain tumors Int J Cancer 83 760 764
14. K Itoh A Yamada 2006 Personalized peptide vaccines: a new therapeutic modality for cancer (review) Cancer Sci 97 970 976 (Pubitemid 44322541)
15. S Izumoto A Tsuboi Y Oka T Suzuki T Hashiba N Kagawa N Hashimoto M Maruno OA Elisseeva T Shirakata M Kawakami Y Oji S Nishida S Ohno I Kawase J Hatazawa S Nakatsuka K Aozasa S Morita J Sakamoto H Sugiyama T Yoshimine 2008 Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme J Neurosurg 108 5 963 971 (Pubitemid 351656845)
16. Janeway CA, Shlomchik MJ, Travers P, Walport M (2004) Using the immune response to attack tumors. In: Janeway CA, Shlomchik MJ, Travers P, Walport J (eds) Immunobiology, 6th edn. Garland Science, New York, pp 630-642
17. T Kikuchi Y Akasaki M Irie S Homma T Abe T Ohno 2001 Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells Cancer Immunol Immunother 50 337 344 (Pubitemid 32835343)
18. T Kikuchi Y Akasaki T Abe T Fukuda H Saotome JL Ryan DW Kufe T Ohno 2004 Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12 J Immunother 27 452 459 (Pubitemid 39447353)
19. KL Knutson ML Disis 2005 Tumor antigen-specific T helper cells in cancer immunity and immunotherapy Cancer Immunol Immunother 54 8 721 728 (Pubitemid 40977140)
20. T Kondo T Setoguchi T Taga 2004 Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line Proc Natl Acad Sci USA 101 781 786 (Pubitemid 38121035)
21. T Kuramoto 1997 Detection of MAGE-1 tumor antigen in brain tumor Kurume Med J 44 43 51 (Pubitemid 127510158)
22. SN Kurapad 1995 Tumor antigens in astrocytic gliomas Glia 15 244 256
23. TE Lallier 1991 Cell lineage and cell migration in the neural crest Ann N Y Acad Sci 615 158 171
24. MF Lipscomb BJ Masten 2002 Dendritic cells: immune regulators in health and disease Physiol Rev 82 97 130 (Pubitemid 34654216)
25. G Liu JS Yu G Zeng D Yin D Xie KL Black H Ying 2004 AIM-2: a novel tumor antigen is expressed and presented by human glioma cells J Immunother 27 220 226 (Pubitemid 39118086)
26. G Liu Y Akasaki HT Khong CJ Wheeler A Das KL Black JS Yu 2005 Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy Oncogene 24 5226 5234 (Pubitemid 41192439)
27. G Liu KL Black JS Yu 2006 Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination Expert Rev Vaccines 5 233 247 (Pubitemid 44183378)
28. LM Liau RM Prins SK Odesa MY Yang MS Lin H Khan-Farooqi H Soto A Lai M Bosch A Boynton TF Cloughesy 2007 Dendritic cell vaccination in combination with TLR-7 agonist, imiquiod following radio-chemotherapy for newly diagnosed glioblastoma Proc Am Soc Clin Oncol 25 2021
29. IK Mellinghoff MY Wang I Vivanco DA Haas-Kogan S Zhu EQ Dia KV Lu K Yoshimoto JH Huang DJ Chute BL Riggs S Horvath LM Liau WK Cavenee PN Rao R Beroukhim TC Peck JC Lee WR Sellers D Stokoe M Prados TF Cloughesy CL Sawyers PS Mischel 2005 Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors N Engl J Med 353 19 2012 2024 (Pubitemid 41609094)
30. T Mine Y Sato M Noguchi T Sasatomi R Gouhara N Tsuda S Tanaka H Shomura K Katagiri T Rikimaru S Shichijo T Kamura T Hashimoto K Shirouzu A Yamada S Todo K Itoh H Yamana 2004 Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing peptide-specific cellular responses Clin Cancer Res 10 929 937 (Pubitemid 38198892)
31. Y Miyagi N Imai T Sasatomi A Yamada T Mine K Katagiri M Nakagawa A Muto S Okouchi H Isomoto K Shirouzu H Yamana K Itoh 2001 Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination of SART3 peptides Clin Cancer Res 7 3950 3962 (Pubitemid 34044613)
32. K Murayama T Kobayashi T Imaizumi K Matsunaga T Kuramoto M Shigemori S Shichijo K Itoh 2000 Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides J Immunother 23 511 518 (Pubitemid 30679327)
33. GN Naumov E Bender D Zurakowski SY Kang D Sampson E Flynn RS Watnick O Straume LA Akslen J Folkman N Almog 2006 A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype J Natl Cancer Inst 98 316 325 (Pubitemid 43338211)
34. FO Nestle S Alijagic M Gilliet Y Sun S Grabbe R Dummer G Burg D Schadendorf 1998 Vaccination of melanoma patients with peptide- or tumor lysate pulsed dendritic cells Nat Med 4 328 332 (Pubitemid 28144092)
35. F Okano WJ Storkus WH Chambers IF Pollack H Okada 2002 Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain Clin Cancer Res 8 2851 2855 (Pubitemid 35025729)
36. SA Rosenberg JC Yang DJ Schwartzentruber P Hwu FM Marincola SL Topalian NP Restifo ME Dudley SL Schwarz PJ Spiess JR Wunderlich MR Parkhurst Y Kawakami CA Seipp JH Einhorn DE White 1998 Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Nat Med 4 321 327 (Pubitemid 28144091)
37. SA Rosenberg JC Yang NP Restifo 2004 Cancer immunotherapy: moving beyond current vaccines Nat Med 10 909 915 (Pubitemid 39273730)
38. S Rutkowski S De Vleeschouwer E Kaempgen JE Wolff J Kühl P Demaerel M Warmuth-Metz P Flamen F Van Calenbergh C Plets N Sörensen A Opitz SW Van Gool 2004 Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study Br J Cancer 91 1656 1662 (Pubitemid 39546137)
39. U Sahin M Koslowski O Türeci T Eberle C Zwick B Romeike JR Moringlane K Schwechheimer W Feiden M Pfreundschuh 2000 Expression of cancer testis genes in human brain tumors Clin Cancer Res 6 3916 3922 (Pubitemid 30807083)
40. S Sakaguchi 2005 Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 345 352 (Pubitemid 41716771)
41. JH Sampson GE Archer DD Bigner T Davis HS Friedman T Keler DA Mitchell DA Reardon R Sawaya AB Heimberger 2008 Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM Proc Am Soc Clin Oncol 26 2011
42. M Sasaki K Nakahira Y Kawano H Katakura T Yoshimine K Shimizu SU Kim K Ikenaka 2001 MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma Cancer Res 61 4809 4814 (Pubitemid 32691895)
43. S Sathornsumetee DA Reardon A Desjardins JA Quinn JJ Vredenburgh JN Rich 2007 Molecularly targeted therapy for malignant glioma Cancer 110 1 13 24
44. DL Scarcella 1999 Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers Clin Cancer Res 5 335 341 (Pubitemid 29085187)
45. T Schneider M Sailer S Ansorge R Firsching D Reinhold 2006 Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma J Neurooncol 79 61 65 (Pubitemid 44057419)
46. SK Singh C Hawkins ID Clarke JA Squire J Bayani T Hide RM Henkelman MD Cusimano PB Dirks 2004 Identification of human brain tumour initiating cells Nature 432 396 401 (Pubitemid 39551674)
47. HH Steiner MM Bonsanto P Beckhove M Brysch K Geletneky R Ahmadi R Schuele-Freyer P Kremer G Ranaie D Matejic H Bauer M Kiessling S Kunze V Schirrmacher C Herold-Mende 2004 Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit J Clin Oncol 22 4272 4281 (Pubitemid 41185148)
48. LA Stewart 2002 Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials Lancet 359 1011 1018 (Pubitemid 34286538)
49. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 (Pubitemid 40349501)
50. N Tsuda K Mochizuki M Harada A Sukehiro K Kawano A Yamada K Ushijima T Sugiyama T Nishida H Yamana K Itoh T Kamura 2004 Vaccination with predesignated or evidence-based peptides for patients with recurrent gynecologic cancers J Immunother 27 60 72 (Pubitemid 38076169)
51. N Uchida DW Buck D He MJ Reitsma M Masek TV Phan AS Tsukamoto FH Gage IL Weissman 2000 Direct isolation of human central nervous system stem cells Proc Natl Acad Sci USA 97 14720 14725 (Pubitemid 32016642)
52. R Ueda Y Iizuka K Yoshida T Kawase Y Kawakami M Toda 2004 Identification of a human glioma antigen, SOX6, recognized by patients' sera Oncogene 23 1420 1427 (Pubitemid 38406837)
53. R Ueda K Yoshida T Kawase Y Kawakami M Toda 2007 Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients Int J Cancer 120 1704 1711 (Pubitemid 46399357)
54. P van der Bruggen C Traversari P Chomez C Lurquin E De Plaen B Van den Eynde A Knuth T Boon 1991 A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 254 1643 1647 (Pubitemid 21917508)
55. A Wakkach N Fournier V Brun JP Breittmayer F Cottrez H Groux 2003 Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo Immunity 18 5 605 617 (Pubitemid 36588578)
56. CJ Wheeler A Das G Liu JS Yu KL Black 2004 Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination Clin Cancer Res 10 5316 5326 (Pubitemid 39100466)
57. J Wischhusen MA Friese M Mittelbronn R Meyermann M Weller 2005 HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo J Neuropathol Exp Neurol 64 6 523 528 (Pubitemid 40781155)
58. N Yajima R Yamanaka T Mine N Tsuchiya J Homma M Sano T Kuramoto Y Obata N Komatsu Y Arima A Yamada M Shigemori K Itoh R Tanaka 2005 Immunological evaluation of personalized peptide vaccination for patients with advanced malignant glioma Clin Cancer Res 11 5900 5911 (Pubitemid 41170319)
59. R Yamanaka T Abe N Yajima N Tsuchiya J Homma T Kobayashi M Narita M Takahashi R Tanaka 2003 Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial Br J Cancer 89 1172 1179 (Pubitemid 37363398)
60. R Yamanaka J Homma N Yajima N Tsuchiya M Sano T Kobayashi S Yoshida T Abe M Narita M Takahashi R Tanaka 2005 Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial Clin Cancer Res 11 4160 4167 (Pubitemid 40791581)
61. JS Yu CJ Wheeler PM Zeltzer H Ying DN Finger PK Lee WH Yong F Incardona RC Thompson MS Riedinger W Zhang RM Prins KL Black 2001 Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration Cancer Res 61 842 847 (Pubitemid 32175145)
62. JS Yu G Liu H Ying WH Yong KL Black CJ Wheeler 2004 Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Res 64 4973 4979 (Pubitemid 38924545)
63. X Yuan J Curtin Y Xiong G Liu S Waschsmann-Hogiu DL Farkas KL Black JS Yu 2004 Isolation of cancer stem cells from adult glioblastoma multiforme Oncogene 23 9392 9400 (Pubitemid 40069671)